In addition to indication benchmarks based on 18 years of historical drug development data, GlobalData also tracks the likelihood of phase change and approval scores for specific drugs. The attributes of the drug, the company, and its clinical trials play an important role in drug-specific PTSR and likelihood of approval.
BW-20507 is being developed to treat chronic hepatitis B virus (HBV) infection. The therapeutic candidate is administered as a solution by the subcutaneous route.
Argo Biopharma Australia (Argo Biopharma) is a healthcare services provider specializing in research, development and other related services. Argo Biopharma is headquartered in Adelaide, South Australia, Australia.
For complete information on BW-20507 drug-specific PTSR and LoA scores, purchase the report here.
Desde
GlobalData’s unparalleled proprietary data combines expertise with cutting-edge technology, allowing you to decipher what’s happening in the market. You can make smarter decisions and gain a future-proof advantage over your competitors.
Editors Activision, Inc. Developers superego games Release date 2006 Gender Adventure Game Rating Game Description…
Editors Terraglyph Interactive Studios, Warner Bros. Interactive Entertainment. Developers Terraglifo interactive studios Release date nineteen…
Editors Sega, Digital Images, Screaming Villains, Limited Run Games Developers Digital Images, Inc. Release date…
Editors Davilex Games BV Developers Davilex Games BV Release date 1998 Gender Careers Game Rating…
Editors Sony Computer Entertainment, Disney Interactive Studios Developers High voltage software Release date 2002 Gender…
Editors Davilex Games BV Developers Davilex Games BV Release date 1999 Gender Careers Game Rating…